
News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
The Antimicrobials Working Group Announces Appointment of Christine Ann Miller as Board Chair
January 17, 2023Press ReleaseWASHINGTON, Jan. 17, 2023 /PRNewswire/ -- The Antimicrobials Working Group (AWG), an industry-led coalition of antimicrobial companies, announced today the...
Cidara Therapeutics and Melinta Therapeutics Announce Publication of Data from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in The Lancet
November 28, 2022Press Release Publication details the efficacy and safety of rezafungin dosed once-weekly versus the current of care dosed once-daily Rezafungin PDUFA target action date is...
Melinta Therapeutics & OptimizeRx Announce 2022 Innovate4Outcomes Event
November 28, 2022Press Release Competition To Focus On Improving Diverse Patients’ Access to Treatment And Responses to Treatment for Antimicrobial Resistance PARSIPPANY, N.J.–Melinta...